Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
15
Data detailed in 'Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case- control studies' have been presented. Although cigarette smoking and alcohol consumption increase risk for head and neck cancers, there have been few attempts to model risks quantitatively and to formally evaluate cancer site-specific risks.
07
A U.S. Phase 1 clinical trial is under way to determine if a new anti-cancer drug is safe and effective for use in patients with solid cancer tumors. The drug, currently called EP-100, is designed to treat common breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers. It is being tested by TGen Clinical Research Services at Scottsdale (Ariz.) Healthcare's Piper Cancer Center.
05
Peregrine Pharmaceuticals, Inc. today reported additional positive results in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in patients with non- small cell lung cancer (NSCLC).
01
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage.
Data published in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care.
29
Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.
26
The doctors told Susan Smedley Gerber that her lung cancer wasn't caused by smoking but in many ways it didn't matter. She found herself facing the same stigma and same reactions that thousands of lung cancer patients fight in addition to their cancer.
21
A new biology, diagnosis and treatment guide issued by U.S. researchers finds that lung cancer in those who have never smoked is different from that of smokers. Dr. Charles M. Rudin of The Johns Hopkins Kimmel Cancer Center in Baltimore said exposures to second-hand smoke and radon gas are thought to play important roles in causing the disease in never-smokers.
In simultaneous releases published around across the globe today, the World Health Organization (WHO) called for stronger action against indoor radon, the leading cause of lung cancer among U.S. and Canadian non-smokers.
17
According to recent research published in the American Journal of Clinical Oncology - Cancer Clinical Trials, This phase I study was designed to determine the maximum tolerated dose (MTD) and preliminary efficacy of docetaxel with concurrent radiotherapy (RT), in high-risk squamous cell carcinoma of the head and neck.
We care about your feedback. Let us know how we can improve your CancerCompass experience.